These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6332882)

  • 1. Use of covalently bound cord factor analog to increase tumor immunogenicity.
    Eggers AE; Tarmin L; Ginsburg S
    J Biol Response Mod; 1984 Aug; 3(4):413-22. PubMed ID: 6332882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical enhancement of tumor immunogenicity.
    Eggers AE; Hibbard CA; Civin CI; Wunderlich JR
    J Immunol; 1980 Oct; 125(4):1737-44. PubMed ID: 6967915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell nature of adjuvant peptide--induced antitumor cell-mediated cytotoxicity.
    Eggers AE; Tarmin L
    J Biol Response Mod; 1984 Aug; 3(4):387-90. PubMed ID: 6332881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT
    Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of muramyl dipeptide analogs in combination with trehalose dimycolate against aerogenic influenza virus and Mycobacterium tuberculosis infections in mice.
    Masihi KN; Brehmer W; Lange W; Ribi E; Schwartzman S
    J Biol Response Mod; 1984 Dec; 3(6):663-71. PubMed ID: 6439830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Original H-2d and alien H-2k-like antigens of a BALB/c fibrosarcoma as defined by in vitro and in vivo studies of cell-mediated immunity.
    Sensi M; Carbone G; Parmiani G
    Eur J Immunol; 1980 Sep; 10(9):671-8. PubMed ID: 6158452
    [No Abstract]   [Full Text] [Related]  

  • 7. Brucella abortus vaccines: comparison of protection provided by immunopotentiated 45/20 bacterins and live strain 19 vaccine in guinea pigs.
    Woodard LF; Toone NM; Jasman RL
    Am J Vet Res; 1981 Nov; 42(11):1959-62. PubMed ID: 6802042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant.
    Chaitra MG; Nayak R; Shaila MS
    Vaccine; 2007 Oct; 25(41):7168-76. PubMed ID: 17709160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine.
    Murahata RI; Mitchell MS
    J Natl Cancer Inst; 1982 Sep; 69(3):607-12. PubMed ID: 6981020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH; Gurish MF; Daynes RA
    Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell-mediated antitumor immune response induced by oncofetal antigens.
    Gautam S; Deodhar SD
    J Natl Cancer Inst; 1981 Oct; 67(4):939-45. PubMed ID: 6974275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytotoxic activity in the course of antitumoral cellular immunity].
    Firket H; Schaaf-Lafontaine N
    Bull Mem Acad R Med Belg; 1978 Jul; 133(7):389-401. PubMed ID: 309778
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of T and B-lymphocytes in macrophage migration inhibition in mice with methylcholanthrene-induced sarcoma].
    Galussio JC; Fridman JL; Tessler J
    Medicina (B Aires); 1977; 37(3):264-70. PubMed ID: 302386
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
    Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
    Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant effect of cord factor, a Mycobacterial lipid component (author's transl)].
    Saito R
    Kekkaku; 1975 May; 50(4-5):91-103. PubMed ID: 1142579
    [No Abstract]   [Full Text] [Related]  

  • 16. Properties of a M(r) 110,000 tumor rejection antigen of the chemically induced BALB/c Meth A sarcoma.
    De Leo AB; Becker M; Lu L; Law LW
    Cancer Res; 1993 Apr; 53(7):1602-7. PubMed ID: 7680955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel muramyl dipeptide adjuvant, N-acetyl-D-glucosaminyl-(beta 1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP).
    Hornung RL; Longo DL; Gowda VL; Kwak LW
    Ther Immunol; 1995 Feb; 2(1):7-14. PubMed ID: 7553072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gamma-Interferon plays a key role in T-cell-induced tumor regression.
    Tuttle TM; McCrady CW; Inge TH; Salour M; Bear HD
    Cancer Res; 1993 Feb; 53(4):833-9. PubMed ID: 8428364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM
    Vopr Onkol; 1973; 19(11):54-60. PubMed ID: 4785975
    [No Abstract]   [Full Text] [Related]  

  • 20. Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model.
    Fernando GJ; Stewart TJ; Tindle RW; Frazer IH
    J Immunol; 1998 Sep; 161(5):2421-7. PubMed ID: 9725239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.